Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 12, 2026 16:46 ET | Source: Stran & Company, Inc.

Stran & Company Reports $31.2 Million in Revenue and Achieves EBITDA of $1.0 Million for the First Quarter of 2026

QUINCY, Mass., May 12, 2026 (GLOBE NEWSWIRE) -- Stran & Company, Inc. ("Stran" or the "Company") (NASDAQ: SWAG) (NASDAQ: SWAGW), a leading outsourced marketing solutions provider that leverages...
May 12, 2026 16:30 ET | Source: XMax Inc.

XMax Inc. Announces Ticker Symbol Change to “XMAX”

LOS ANGELES, May 12, 2026 (GLOBE NEWSWIRE) -- XMax Inc. (NASDAQ: XWIN, the “Company” or “XMax”) today announced that its ticker symbol will change from “XWIN” to “XMAX,” effective at market open on...
May 12, 2026 16:30 ET | Source: USA Rare Earth, Inc.

USA Rare Earth Awarded $14.2 Million Texas Semiconductor Innovation Fund Grant to Accelerate Round Top Mountain Heavy Rare Earth Project

STILLWATER, Okla., May 12, 2026 (GLOBE NEWSWIRE) -- USA Rare Earth, Inc. (Nasdaq: USAR) (the Company) today announced that the State of Texas has awarded the Company a $14,177,600 grant from the...
May 12, 2026 16:18 ET | Source: Orchestra BioMed Holdings, Inc.

Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates

Orchestra BioMed targeting enrollment completion of BACKBEAT Global Pivotal Trial (“BACKBEAT Trial”) by the end of Q3 2026Medtronic (NYSE: MDT) and Orchestra BioMed intend to pursue late-breaking...
May 12, 2026 16:15 ET | Source: Palisade Bio, Inc.

Palisade Bio Reports First Quarter 2026 Financial Results and Highlights Continued Clinical Progress of PALI-2108

Advancing potentially best-in-class once-daily oral, locally-activated PDE4 inhibitor prodrug for treatment of IBD Phase 2 Ulcerative Colitis (UC) trial expected to commence 3Q 2026 Strong balance...
May 12, 2026 16:15 ET | Source: AnaptysBio, Inc.

Anaptys Announces First Quarter 2026 Financial Results and Provides Business Update

Completed spin-off of First Tracks Biotherapeutics, Inc., its former biopharma operations businessNow exclusively manages the financial collaborations for Jemperli with GSK and imsidolimab with...
May 12, 2026 16:15 ET | Source: Scorpio Tankers Inc.

Scorpio Tankers Inc. Announces Closing of Convertible Senior Notes due 2031 and Concurrent Stock Repurchase

MONACO, May 12, 2026 (GLOBE NEWSWIRE) -- Scorpio Tankers Inc. (NYSE: STNG) (the “Company”) announced today that it has closed its previously announced private offering (the “Offering”) for...
May 12, 2026 16:14 ET | Source: Public Policy Holding Company, Inc.

Public Policy Holding Company, Inc. Announces Q1 2026 Financial Results

Strong Revenue Growth Demonstrating Success of Company Strategy Revenue growth of 27.5% with organic revenue growth of 5.1% compared to Q1 2025Completed significant talent additions, and announced an...
May 12, 2026 16:12 ET | Source: Ring Energy, Inc.

Ring Energy Announces Proposed Public Offering of Common Stock

THE WOODLANDS, Texas, May 12, 2026 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) announced today that it has commenced an underwritten public offering of...
May 12, 2026 16:08 ET | Source: Solid Biosciences Inc.

Solid Biosciences Reports First Quarter 2026 Financial Results and Provides Business Updates

- Duchenne (SGT-003): First participant dosed in the Phase 3 IMPACT DUCHENNE clinical trial, receipt of positive opinion on the Company’s Pediatric Investigation Plan from the European Medicines...